-The Telegraph The Union urban development ministry has proposed three new taxes on private vehicle owners: on vehicle purchases, petrol and insurance. The aim is to fund public transport in cities and deter the use of private vehicles The Rs 40,000 crore that the ministry proposes to raise annually through the “green surcharge”, “green cess” and “urban transport tax” is to go to a national urban transport fund that will finance transport schemes. Urban...
More »SEARCH RESULT
Poverty data based on consumption expenditure gives skewed result-Rajesh Shukla
One would expect a debate such as the current one on poverty estimates to be conducted with a serious exploration of its various facets. However, instead of a comprehensive, fact-driven exploration, the debate has yielded aspersions on the intellectual honesty of academicians. Although given its electoral connotations, one does expect political biases to creep into the debate, the barrage of criticism hurled at the Planning Commission, over its affidavit in...
More »Delhi's irony: Urban Poverty-Srinand Jha
Each time 25 year old Salma takes her one year old son Zubair to the Batla Clinic (a private clinic in Delhi) for a shot of the DPT, the cost of transportation and the vaccine adds up to approximately Rs.500. When it is time for Zubair to take the next immunization dose, Salma may find that the expenses have entirely spiraled out of her reach. New vaccines and expensive brands of baby...
More »Cheap generics no panacea for India's poorest
-Reuters Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital. "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...
More »A life saver-Shamnad Basheer
Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...
More »